دورة المؤشرنت للتحليل الفني
50 دينار كويتي
ormp
- بادئ الموضوع al-karrar
- تاريخ البدء
qw80
عضو نشط
- التسجيل
- 4 سبتمبر 2007
- المشاركات
- 1,379
Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)
Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)
Wed Jun 04 08:45:00 2008
EDT
JERUSALEM, June 4, 2008 /PRNewswire-FirstCall via COMTEX News Network/ --
Oramed Pharmaceuticals, Inc.
(OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery
systems, announced today that it has been selected to display its abstract,
entitled Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin in
Healthy Subjects, at the upcoming 68th Annual American Diabetes Association's
Scientific Sessions Conference in San Francisco, highlighting the successful
results from its oral insulin trials on healthy volunteers.
The abstract will also be printed in the Scientific Sessions Abstract
Book, the June 2008 supplement to the journal Diabetes.
Oramed's technology will be included in an oral presentation by Prof. Dr.
Lutz Heinemann, CEO of Profil Institute for Metabolic Research,
"Pharmacokinetics and Pharmacodynamics of Alternate Insulin Delivery
Systems," on Saturday, June 7, 2008 from 4 pm to 6 pm.راح يقدمون تقريرهم عن دراستهم السبت القادم؟التاريخ والوقت الي بالاحمر... هذا احتمال سبب تحرك السهم هاليومين كن حذر معاك غدا الجمعه...ركز...
Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)
Wed Jun 04 08:45:00 2008
EDT
JERUSALEM, June 4, 2008 /PRNewswire-FirstCall via COMTEX News Network/ --
Oramed Pharmaceuticals, Inc.
(OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery
systems, announced today that it has been selected to display its abstract,
entitled Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin in
Healthy Subjects, at the upcoming 68th Annual American Diabetes Association's
Scientific Sessions Conference in San Francisco, highlighting the successful
results from its oral insulin trials on healthy volunteers.
The abstract will also be printed in the Scientific Sessions Abstract
Book, the June 2008 supplement to the journal Diabetes.
Oramed's technology will be included in an oral presentation by Prof. Dr.
Lutz Heinemann, CEO of Profil Institute for Metabolic Research,
"Pharmacokinetics and Pharmacodynamics of Alternate Insulin Delivery
Systems," on Saturday, June 7, 2008 from 4 pm to 6 pm.راح يقدمون تقريرهم عن دراستهم السبت القادم؟التاريخ والوقت الي بالاحمر... هذا احتمال سبب تحرك السهم هاليومين كن حذر معاك غدا الجمعه...ركز...
دورة المؤشرنت للتحليل الفني
50 دينار كويتي